Other very important participating factors, the NLRP3 and AIM2 inflammasomes, have appeared as crucial players in regulating certain hematological pathologies, e.g., myelodysplastic syndrome (MDS), MPNs, cardiovascular risk, and leukemia [58,59]. Here, NLRP3 is linked to myelodysplastic syndrome.